Drugs / Locoid Lipocream
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | LOCOID LIPOCREAM | — | 2009-10-19 | fda.gov ↗ |
| Approved | US (FDA) | LOCOID LIPOCREAM | — | 1997-09-08 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02153762 | Apr 2013 → Jan 2014 | atopic eczema | Icahn School of Medicine at Mount Sinai | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Locoid Lipocream | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02153762 ↗ |
| Route | Topical | “Patients were randomized to apply Locoid Lipocream followed by Hylatopic Plus lotion on either the right or left side target lesion with the reverse order on the other side.” NCT02153762 ↗ |